Myriad Genetics Inc
XBER:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XBER:MYD
|
US |
|
Premia Finance SpA Societa di Mediazione Creditizia
F:81U
|
IT |
|
P
|
Primo Water Corp
NYSE:PRMW
|
US |
|
T
|
Target Corp
XETRA:DYH
|
US |
|
Komercni Banka as
PSE:KOMB
|
CZ |
|
LATAM Airlines Group SA
OTC:LTMAY
|
CL |
|
Element Fleet Management Corp
TSX:EFN
|
CA |
|
E
|
Elica SpA
F:7L4
|
IT |
|
T
|
Trillion Energy International Inc
OTC:TRLEF
|
CA |
|
Extra Space Storage Inc
NYSE:EXR
|
US |
|
W
|
Westinghouse Air Brake Technologies Corp
F:WB2
|
US |
|
D
|
Dominion Energy Inc
F:DOD
|
US |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
|
Marqeta Inc
F:8QJ
|
US |
|
E
|
Estee Lauder Companies Inc
LSE:0JTM
|
US |
|
M
|
Mediobanca Banca di Credito Finanziario SpA
SWB:ME9
|
IT |
|
P
|
Prudential PLC
HKEX:2378
|
UK |
|
S
|
Steadfast Group Ltd
F:1S6
|
AU |
|
Nexgel Inc
NASDAQ:NXGL
|
US |
|
Atlas Arteria Group
ASX:ALX
|
AU |
|
L
|
Lumentum Holdings Inc
F:LU2
|
US |
|
D
|
Dollar General Corp
LSE:0IC7
|
US |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
V
|
Vonovia SE
OTC:VNNVF
|
DE |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
360.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.3m USD. This includes both short-term (0 USD) and long-term (120.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
